Best Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.
Industry: Biotechnology
F
Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDXG | MIMEDX GROUP INC | $1.11B | 19.20% | 14.30% | 20.39% | 49.90% | 0.34 | 4.41 | 82.00% | 10.40% | 13.54% | ||
| INCY | INCYTE CORP | $19.94B | 29.80% | 20.40% | 31.86% | 76.00% | 0.36 | 3.20 | 92.90% | 24.70% | 33.05% | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.44B | N/A | -7.40% | 22.20% | 6.00% | -2.08 | 2.25 | 97.00% | -6.40% | 11.15% | ||
| TBPH | THERAVANCE BIOPHARMA INC | $766.50M | 6.90% | 3.50% | 11.49% | 15.90% | 0.90 | 6.71 | 100.00% | 16.90% | 55.25% | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.73B | 16.70% | 11.50% | 15.80% | 14.50% | 0.50 | 5.23 | 89.50% | 23.30% | 25.77% | ||
| TVTX | TRAVERE THERAPEUTICS INC | $3.09B | -178.70% | -15.80% | -19.15% | -13.30% | 6.32 | 2.75 | 97.60% | -20.30% | -17.73% | ||
| ONC | BEONE MEDICINES LTD | $34.35B | -5.10% | -3.00% | -2.23% | -4.10% | 0.67 | 1.95 | 85.50% | -3.90% | -1.99% | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $549.78M | 438.90% | 57.00% | 88.99% | 124.70% | 1.52 | 2.02 | 91.50% | 36.50% | 39.89% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $57.35B | 26.10% | 1.00% | 3.95% | 2.60% | 19.74 | 2.54 | 83.90% | 1.40% | 4.06% | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $3.03B | -29.70% | -12.50% | -10.57% | -9.70% | 1.35 | 3.50 | 90.00% | -13.90% | -9.02% | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $250.18M | 49.30% | 18.20% | 39.47% | 61.20% | 1.02 | 1.53 | 72.40% | 16.40% | 18.58% | ||
| AKBA | AKEBIA THERAPEUTICS INC | $556.79M | N/A | -18.90% | -9.98% | -30.20% | 11.62 | 2.23 | 68.00% | -24.50% | -11.82% | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.60B | N/A | -9.90% | -2.16% | -1.70% | -18.34 | 1.95 | 82.20% | -13.00% | -2.10% | ||
| TGTX | TG THERAPEUTICS INC | $5.35B | 26.10% | 9.60% | 18.37% | 16.60% | 1.54 | 3.86 | 87.00% | 13.30% | 21.47% | ||
| INVA | INNOVIVA INC | $1.14B | 5.70% | 3.00% | 7.86% | 9.00% | 0.87 | 2.64 | 86.60% | 10.40% | 23.09% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $3.56B | -24.80% | -8.50% | -7.40% | -10.50% | 1.85 | 3.13 | 79.00% | -13.60% | -10.02% | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.78B | 141.60% | 27.90% | 55.18% | 32.60% | 3.41 | 1.59 | 84.50% | 47.90% | 61.45% | ||
| ZYME | ZYMEWORKS INC | $1.32B | -31.60% | -24.00% | -29.74% | -33.70% | 0.31 | 4.71 | 100.00% | -121.70% | -114.77% | ||
| GMAB | GENMAB A | $18.42B | 24.70% | 19.90% | 30.06% | 75.00% | 0.22 | 6.22 | 94.40% | 37.60% | 52.88% | ||
| CRMD | CORMEDIX INC | $782.70M | 22.60% | 17.00% | 14.95% | 53.00% | 0.30 | 4.21 | 95.20% | 20.80% | 20.85% | ||
| NAGE | NIAGEN BIOSCIENCE INC | $576.61M | 35.50% | 23.80% | 26.49% | 199.80% | 0.43 | 3.88 | 63.60% | 15.20% | 15.76% | ||
| KRYS | KRYSTAL BIOTECH INC | $5.73B | 15.20% | 13.80% | 16.05% | 26.50% | 0.09 | 9.68 | 93.40% | 40.80% | 46.98% | ||
| ARGX | ARGENX SE | $50.43B | 24.70% | 21.40% | 10.88% | 20.20% | 0.18 | 5.60 | -19,733.10% | 78,552.00% | 40,946.87% | ||
| XOMA | XOMA ROYALTY CORP | $399.62M | -15.30% | -5.60% | -2.21% | -2.40% | 1.81 | 4.88 | 100.00% | -27.60% | -9.92% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.75B | -9.20% | -8.10% | -9.15% | -17.30% | 0.15 | 5.45 | 93.00% | -40.40% | -43.10% | ||
| FOLD | AMICUS THERAPEUTICS INC | $2.73B | -19.80% | -4.80% | 3.89% | 3.80% | 2.99 | 3.21 | 90.40% | -6.70% | 4.41% | ||
| ABUS | ARBUTUS BIOPHARMA CORP | $877.98M | -59.20% | -44.10% | -55.10% | -68.90% | 0.25 | 20.53 | 100.00% | -351.90% | -351.17% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.84B | 7.50% | 5.60% | 8.26% | 14.10% | 0.33 | 3.85 | 87.50% | 6.00% | 8.13% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.69B | 26.30% | 17.70% | 25.99% | 53.80% | 0.43 | 3.84 | 78.30% | 23.40% | 31.22% | ||
| APLS | APELLIS PHARMACEUTICALS INC | $2.62B | 18.90% | 5.00% | 11.77% | 12.30% | 1.64 | 3.54 | 88.80% | 4.40% | 9.02% | ||
| ASND | ASCENDIS PHARMA A | $12.20B | N/A | -33.40% | -107.48% | -42.00% | -6.59 | 1.04 | 85.30% | -92.70% | -51.29% | ||
| VCYT | VERACYTE INC | $2.85B | 2.80% | 2.60% | 2.83% | 23.70% | 0.10 | 5.10 | 68.00% | 7.10% | 7.57% | ||
| LXRX | LEXICON PHARMACEUTICALS INC | $494.22M | -83.60% | -42.20% | -56.64% | -49.10% | 0.74 | 4.17 | 99.20% | -206.40% | -184.91% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $109.22B | 22.10% | 15.90% | 22.07% | 31.10% | 0.40 | 2.52 | 86.10% | 31.90% | 38.45% | ||
| FBIO | FORTRESS BIOTECH INC | $72.60M | -87.40% | -15.80% | -0.19% | -0.40% | 2.79 | 1.92 | 70.90% | -40.60% | -0.34% | ||
| DOMH | DOMINARI HOLDINGS INC | $74.60M | -36.60% | -30.20% | -20.49% | -35.90% | 0.24 | 3.65 | 100.00% | -36.00% | -36.01% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.62B | 27.50% | 23.80% | 31.66% | 413.50% | 0.14 | 6.71 | 85.80% | 37.40% | 48.70% | ||
| FENC | FENNEC PHARMACEUTICALS INC | $226.27M | N/A | -24.70% | -23.30% | -24.30% | -7.01 | 4.85 | 89.90% | -36.10% | -25.51% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $67.50B | 15.30% | 11.90% | 14.51% | 15.50% | 0.30 | 4.06 | 85.40% | 32.10% | 36.41% | ||
| EXEL | EXELIXIS INC | $10.25B | 27.70% | 21.10% | 33.12% | 32.40% | 0.32 | 3.51 | 96.60% | 27.00% | 34.78% | ||
| RPRX | ROYALTY PHARMA PLC | $21.75B | 10.20% | 5.70% | 7.52% | 5.50% | 0.93 | 1.26 | 100.00% | 44.30% | 55.83% | ||
| VALN | VALNEVA SE | $734.85M | -35.30% | -13.60% | -11.90% | -10.30% | 1.54 | 2.27 | 49.00% | -34.10% | -21.03% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $573.14M | 4.00% | 1.30% | 13.14% | 23.30% | 1.19 | 7.85 | 72.00% | 4.30% | 48.18% | ||
| FTRE | FORTREA HOLDINGS INC | $910.80M | -95.00% | -31.10% | -49.46% | -65.70% | 3.81 | 1.02 | 19.70% | -37.60% | -34.25% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $2.64B | -60.90% | -23.00% | -27.07% | -22.50% | 1.76 | 2.84 | 66.00% | -59.10% | -53.35% | ||
| MESO | MESOBLAST LTD | $2.06B | -19.00% | -14.10% | -11.56% | -103.10% | 0.31 | 1.99 | 70.20% | -593.90% | -458.45% | ||
| SLGL | SOL-GEL TECHNOLOGIES LTD | $98.90M | -10.20% | -8.40% | -9.93% | -14.20% | 0.23 | 7.32 | 100.00% | -14.20% | -14.25% | ||
| INBX | INHIBRX BIOSCIENCES INC | $1.18B | -137.80% | -76.30% | -91.16% | -390.10% | 2.09 | 4.98 | 100.00% | -11,692.40% | -11,275.86% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $237.99M | N/A | -28.00% | -50.79% | -44.10% | -3.95 | 2.62 | 100.00% | -311.90% | -311.90% | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $97.27M | -8.30% | 6.60% | 44.55% | 25.20% | -2.05 | 1.70 | 81.20% | 3.10% | 5.27% | ||
| SPRO | SPERO THERAPEUTICS INC | $133.94M | -120.30% | -55.60% | -113.62% | -424.60% | 0.89 | 3.98 | 100.00% | -110.30% | -110.34% | ||
| VCEL | VERICEL CORP | $1.85B | 2.50% | 1.70% | 2.00% | 2.00% | 0.42 | 4.97 | 73.50% | 2.90% | 3.16% | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.82B | 20.00% | 16.10% | 15.26% | 17.50% | 0.26 | 3.06 | 98.40% | 18.40% | 14.00% | ||
| OVID | OVID THERAPEUTICS INC | $98.13M | -58.80% | -43.20% | -55.73% | -55.70% | 0.39 | 4.72 | 100.00% | -574.00% | -574.02% | ||
| BNTX | BIONTECH SE | $25.00B | -3.00% | -2.60% | -2.32% | -5.00% | 0.16 | 7.12 | 82.50% | -18.10% | -14.07% | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $190.56M | 14.70% | 8.70% | 16.88% | 29.10% | 0.57 | 2.72 | 57.50% | 10.10% | 14.82% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.15B | 8.80% | 7.10% | 10.12% | 12.20% | 0.26 | 4.83 | 81.30% | 16.80% | 22.30% | ||
| NTHI | NEONC TECHNOLOGIES HOLDINGS INC | $195.23M | N/A | N/A | N/A | N/A | -1.25 | 0.11 | N/A | N/A | N/A | ||
| EVAX | EVAXION A | $36.45M | -320.20% | -63.60% | -59.92% | -74.40% | 2.61 | 3.42 | 100.00% | -377.00% | -323.11% | ||
| UTHR | UNITED THERAPEUTICS CORP | $18.89B | 18.80% | 16.80% | 24.85% | 31.70% | 0.12 | 6.40 | 88.60% | 40.70% | 54.04% | ||
| XNCR | XENCOR INC | $994.24M | -25.70% | -18.40% | -17.20% | -13.80% | 0.42 | 5.34 | 100.00% | -116.40% | -91.72% | ||
| MDGL | MADRIGAL PHARMACEUTICALS INC | $9.19B | -38.40% | -27.30% | -32.75% | -34.00% | 0.46 | 5.11 | 96.30% | -54.70% | -52.01% | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $3.74B | 35.30% | 21.70% | 31.92% | 64.00% | 0.48 | 2.88 | 92.00% | 23.00% | 26.58% | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $8.39B | -10.00% | -3.50% | -3.40% | -4.00% | 1.95 | 1.62 | 88.70% | -9.90% | -7.37% | ||
| IRD | OPUS GENETICS INC | $128.20M | -366.70% | -142.10% | -315.46% | 614.70% | 1.21 | 1.90 | 100.00% | -377.90% | -377.89% | ||
| IMCR | IMMUNOCORE HOLDINGS PLC | $1.63B | -5.90% | -2.10% | -0.47% | -0.50% | 1.72 | 6.36 | 99.00% | -6.50% | -1.24% | ||
| LQDA | LIQUIDIA CORP | $2.17B | -223.90% | -58.50% | -69.15% | -84.80% | 15.95 | 2.49 | 69.30% | -732.20% | -640.62% | ||
| RLAY | RELAY THERAPEUTICS INC | $1.19B | -44.20% | -39.50% | -43.73% | -46.50% | 0.11 | 19.96 | 100.00% | -4,341.50% | -4,341.53% | ||
| NBTX | NANOBIOTIX SA | $853.79M | N/A | -78.30% | 217.34% | -442.80% | -1.66 | 0.63 | 100.00% | -508.40% | -382.20% | ||
| PTCT | PTC THERAPEUTICS INC | $5.38B | -71.70% | 29.30% | 39.40% | 123.50% | -15.30 | 3.89 | 96.90% | 33.60% | 45.78% | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $224.61M | 4.70% | 3.50% | 3.19% | 5.20% | 0.25 | 9.24 | 100.00% | 7.30% | 7.27% | ||
| CYTK | CYTOKINETICS INC | $7.17B | N/A | -43.70% | -52.14% | -29.40% | -5.75 | 5.99 | 100.00% | -3,201.50% | -2,996.11% | ||
| SLNO | SOLENO THERAPEUTICS INC | $3.49B | -73.70% | -56.70% | -57.20% | -67.90% | 0.38 | 15.13 | 97.90% | -554.50% | -545.40% | ||
| ASMB | ASSEMBLY BIOSCIENCES INC | $239.14M | -149.00% | -39.00% | -116.58% | -139.30% | 3.46 | 1.64 | N/A | N/A | N/A | ||
| NAMS | NEWAMSTERDAM PHARMA CO NV | $4.17B | -24.60% | -22.60% | -21.28% | -324.10% | 0.05 | 21.09 | 100.00% | -258.90% | -258.91% | ||
| ARDX | ARDELYX INC | $1.44B | -36.90% | -12.60% | -9.25% | -7.50% | 2.15 | 4.41 | 88.20% | -14.20% | -9.35% | ||
| TARS | TARSUS PHARMACEUTICALS INC | $2.95B | -32.40% | -21.00% | -20.45% | -29.10% | 0.49 | 5.26 | 93.40% | -31.10% | -28.01% | ||
| TECH | BIO-TECHNE CORP | $9.53B | 3.60% | 2.80% | 4.49% | 8.10% | 0.33 | 3.46 | 64.80% | 6.00% | 8.77% | ||
| NVO | NOVO NORDISK A S | $219.28B | 77.90% | 24.20% | 51.26% | 67.90% | 1.87 | 0.78 | 83.90% | 35.60% | 45.13% | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $231.31M | -89.00% | -27.30% | -33.61% | -29.90% | 2.80 | 5.00 | 100.00% | -142.00% | -133.00% | ||
| ANAB | ANAPTYSBIO INC | $1.01B | -367.00% | -30.60% | -44.21% | -20.90% | -8.49 | 8.22 | 100.00% | -107.70% | -107.59% | ||
| TRAW | TRAWS PHARMA INC | $16.88M | -1,812.50% | 512.70% | 1,063.00% | -1,416.90% | 0.89 | 2.09 | 100.00% | 3,028.20% | 3,028.25% | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $15.06M | -94.70% | -76.50% | -121.93% | -192.10% | 0.15 | 7.42 | N/A | N/A | N/A | ||
| OKYO | OKYO PHARMA LTD | $101.55M | N/A | -180.40% | 127.79% | 102.70% | -1.66 | 0.40 | N/A | N/A | N/A | ||
| ORMP | ORAMED PHARMACEUTICALS INC | $96.77M | -16.20% | -15.40% | -22.17% | -33.00% | 0.05 | 26.82 | 0.60% | -1,210.90% | -1,750.95% | ||
| GYRE | GYRE THERAPEUTICS INC | $708.86M | 5.80% | 3.10% | 5.16% | 7.40% | 0.25 | 5.40 | 95.90% | 4.10% | 6.85% | ||
| ABEO | ABEONA THERAPEUTICS INC | $245.11M | 77.70% | 39.80% | 36.32% | 85.00% | 0.51 | 6.73 | 100.00% | 14,310.50% | 19,223.25% | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $5.48B | -41.10% | -11.60% | -5.41% | -3.60% | 1.65 | 4.87 | 100.00% | -25.90% | -11.19% | ||
| PTHS | PELTHOS THERAPEUTICS INC | $104.07M | N/A | -689.50% | 131.48% | 454.90% | -1.13 | 0.11 | N/A | N/A | N/A | ||
| IMNM | IMMUNOME INC | $1.48B | -87.40% | -74.80% | -77.68% | -279.60% | 0.10 | 12.13 | 100.00% | -1,687.10% | -1,687.08% | ||
| TSHA | TAYSHA GENE THERAPIES INC | $1.22B | -79.90% | -45.70% | -30.08% | -175.00% | 0.34 | 12.48 | 100.00% | -1,145.00% | -1,143.96% | ||
| STOK | STOKE THERAPEUTICS INC | $1.43B | 18.30% | 15.50% | 11.73% | 30.70% | 0.15 | 6.98 | 100.00% | 26.30% | 20.30% | ||
| AXSM | AXSOME THERAPEUTICS INC | $6.84B | -357.20% | -37.10% | -72.12% | -135.20% | 8.08 | 1.57 | 91.90% | -40.90% | -39.70% | ||
| SRPT | SAREPTA THERAPEUTICS INC | $2.39B | -4.40% | -1.60% | -0.87% | -0.60% | 1.71 | 2.89 | 79.30% | -2.30% | -0.97% | ||
| BBIO | BRIDGEBIO PHARMA INC | $11.94B | N/A | -82.20% | -86.24% | -30.80% | -1.51 | 3.88 | 95.80% | -225.30% | -190.53% | ||
| VRCA | VERRICA PHARMACEUTICALS INC | $33.63M | N/A | -115.50% | -400.01% | -132.00% | -3.24 | 1.26 | 86.50% | -330.50% | -268.91% | ||
| PGEN | PRECIGEN INC | $1.24B | -1,156.80% | -108.40% | -158.28% | -224.80% | -2.93 | 2.71 | -0.70% | -2,868.70% | -2,870.25% | ||
| CDTX | CIDARA THERAPEUTICS INC | $1.33B | -132.70% | -98.60% | -128.03% | 831.10% | 0.35 | 3.87 | 100.00% | -60,589.70% | -60,589.74% | ||
| CVAC | CUREVAC NV | $1.20B | 29.20% | 25.10% | 35.70% | 90.50% | 0.18 | 6.17 | 94.80% | 37.90% | 43.41% | ||
| TTRX | TURN THERAPEUTICS INC | N/A | N/A | N/A | N/A | N/A | 1.44 | 3.20 | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.